lorazepam has been researched along with tetragastrin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Charrier, D; Dangoumau, L; Hamon, M; Puech, AJ; Thiébot, MH | 1 |
| Demazières, A; Erb, G; Hode, Y; Luthringer, R; Mathis, A; Namer, IJ; Schunck, T | 1 |
1 trial(s) available for lorazepam and tetragastrin
| Article | Year |
|---|---|
One milligram of lorazepam does not decrease anxiety induced by CCK-4 in healthy volunteers: investigation of neural correlates with BOLD MRI.
Topics: Adult; Anti-Anxiety Agents; Anxiety; Anxiety Disorders; Attention; Cerebral Cortex; Cross-Over Studies; Gyrus Cinguli; Heart Rate; Humans; Lorazepam; Magnetic Resonance Imaging; Male; Panic; Panic Disorder; Psychiatric Status Rating Scales; Tetragastrin; Young Adult | 2011 |
1 other study(ies) available for lorazepam and tetragastrin
| Article | Year |
|---|---|
Failure of CCK receptor ligands to modify anxiety-related behavioural suppression in an operant conflict paradigm in rats.
Topics: Animals; Anxiety; Behavior, Animal; Conditioning, Operant; Dose-Response Relationship, Drug; Lorazepam; Male; Rats; Rats, Wistar; Receptors, Cholecystokinin; Tetragastrin | 1995 |